[ad_1]
Image: Supplied
Abu Dhabi-based Hayat Biotech hosted domestic and foreign healthcare experts, academics and representatives of the health sector to discuss the future of the UAE’s healthcare system and Abu Dhabi’s role on the international stage.
group discussion entitled Abu Dhabi’s Life Sciences Revolutionfacilitated the exchange of knowledge and experience, and explored priorities and key areas for activation and collaboration.
In his keynote address, Naser Al Yammahi, Deputy CEO of Hayat Biotech, said the company is passionately committed to supporting the Department of Health – Abu Dhabi’s (DoH) ambition to build the city into a global center of excellence for biotechnology and life sciences Vibrant vision.
“We have an unwavering commitment to partnering with international pharmaceutical companies to localize their production and help them achieve their growth goals. Our ultimate goal is to have a lasting impact on the industry globally, transforming biotechnology and the life sciences landscape,” said Al Yammahi.
Hayat BiotechnologyWith a combined annual production capacity of 230 million vials, state-of-the-art biotechnology facilities in Abu Dhabi and Belgrade, Serbia play a vital role in the company’s global ambitions.
Naser Al Yammahi, Deputy CEO of Hayat Biotech, discussed at the Abu Dhabi conference the importance of the life sciences revolution, supporting the development of the health sector and strengthening partnerships to advance research and innovation in life sciences.
– Abu Dhabi Media Office (@ADMediaOffice) June 8, 2023
The company has successfully partnered with international companies that have moved production to factories in the UAE. Hayat Biotech positions itself as the destination of choice for biopharmaceutical companies looking to establish local and regional manufacturing capabilities in the country.
Abu Dhabi boosts appeal of its life science hub
At the same time, due to its strategic location, Abu Dhabi acts as a safe and efficient gateway for global distribution, especially in the healthcare industry.
UAE authorities have taken proactive steps to implement diverse programs and initiatives to create an attractive environment for international businesses in the region.
With its notable advancements in healthcare, the UAE has strengthened its position as an important hub for the logistics, transportation and distribution of medicines, playing an active role in improving global health.
Hayat Biotech, in partnership with IROS, has become the healthcare industry’s preferred partner for clinical research due to its expertise and continued commitment to conducting clinical trials.
In addition to the eight clinical trials already underway in the UAE, the company is continuously developing new and innovative biopharmaceutical products to address unmet medical needs or improve existing treatments.
“Having a clinical trial in Abu Dhabi provides access to a diverse patient population that may not be available in other regions,” said Dr. Nawal Al Kaabi, Senior Consultant at Hayat Biotech. And safety is paramount, which could lead to more accurate results and better treatments.”
Its commitment to medical science makes it a trusted partner for biopharmaceutical companies looking to conduct clinical research and bring new products to market.
As Abu Dhabi continues to establish itself as a leading hub for biopharmaceutical research, development and production, Hayat Biotech plays a key role in driving this advancement.
read: The role of biotechnology and life sciences in UAE healthcare goals
[ad_2]
Source link